2007
DOI: 10.1080/15602210701381985
|View full text |Cite
|
Sign up to set email alerts
|

The MEDMAN project: Evaluation of the medicines management training for community pharmacists

Abstract: Background and Training package: A RCT was conducted to evaluate a community pharmacist-led medicines management service (MEDMAN) for patients with coronary heart disease (CHD). The aim was to evaluate training provided prior to commencement of the service.Method: Questionnaires were mailed to participating English community pharmacists at three time points to assess CHD knowledge, perceived knowledge/skills, and comfort with respect to the new service.Results: Before training (baseline; response rate 63%) pha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 9 publications
(7 reference statements)
0
4
1
Order By: Relevance
“…14 While the most likely explanation for this is that patients thought of additional questions after the I-MUR had been completed, particularly given the time interval between the I-MUR and the patient survey, pharmacist knowledge may have been insufficient. Pharmacists' perceptions of their skills and knowledge was in fact high even before they started to deliver the I-MUR, in contrast to pharmacists in England prior to delivering a similar service ), 12 and while pharmacists in this latter study did perceive their skills and knowledge improved after training, there was no significant change in the perceived skills and knowledge of the pharmacists delivering the I-MUR. The need for more communication and collaboration with GPs regarding the medicines use review (MUR) service in England has been reported.…”
Section: Discussioncontrasting
confidence: 55%
See 1 more Smart Citation
“…14 While the most likely explanation for this is that patients thought of additional questions after the I-MUR had been completed, particularly given the time interval between the I-MUR and the patient survey, pharmacist knowledge may have been insufficient. Pharmacists' perceptions of their skills and knowledge was in fact high even before they started to deliver the I-MUR, in contrast to pharmacists in England prior to delivering a similar service ), 12 and while pharmacists in this latter study did perceive their skills and knowledge improved after training, there was no significant change in the perceived skills and knowledge of the pharmacists delivering the I-MUR. The need for more communication and collaboration with GPs regarding the medicines use review (MUR) service in England has been reported.…”
Section: Discussioncontrasting
confidence: 55%
“…A questionnaire was developed based on an instrument used in a previous study in England ). 12 It was divided into three sections: pharmacists' demographic details; expectations and experiences of delivering the I-MUR service; views about the I-MUR service using a five-point Likert scale plus confidence and comfort in delivering the intervention. Expectations were sought by: i) requesting respondents to select any issue from a list, developed from previous studies, which they thought may be potential barriers to providing the I-MUR and ii) to select the types of pharmaceutical care issues (PCIs) they thought may be identified in the patients, using a validated classification system.…”
Section: Pharmacist Questionnairementioning
confidence: 99%
“…This study suggests problems with the completeness of medication reviews by community pharmacists and lack of uniformity between pharmacists, which may have been affected by the limited training provided [12], but which also bore no relationship to demographic characteristics. This variation may have contributed to the lack of benefit shown in the CPMMP [11].…”
Section: Discussionmentioning
confidence: 99%
“…In line with other studies involving community pharmacists and limited data, there were no significant benefits in terms of quality of life, cost of medicines, health service utilization or prescribing appropriateness in line with the National Service Framework (NSF) for CHD [11]. As part of the evaluation of the CPMMP, the training provided to community pharmacists, which was specifically designed for the project [12], and the reviews they delivered were studied.…”
Section: Introductionmentioning
confidence: 93%
“…Evidences to improve pharmaceuticals practices were seen in previous training intervention studies (Calop et al, 2002; Coggans et al, 2001; Currie et al, 1997; Jaffray et al, 2007; Willis et al, 2016). However, few studies have evaluated the development of the training intervention conducted for community pharmacists to assess its feasibility for implementation and usability for the purpose intended.…”
mentioning
confidence: 86%